This PDF file includes:

• Table S1. Antibacterial and MC-activating capacities of mastoparan analog peptides.
• Fig. S1. Depletion of CTMCs.
• Fig. S2. Correlation between CFU and lesion size.
• Fig. S3. Depletion of neutrophils.
• Fig. S4. Receptor specificity of mastoparan.
• Fig. S5. Detection of granulated MCs by toluidine blue staining.
• Fig. S6. Comparison of mastoparan with triple antibiotic.
• Fig. S7. Mastoparan treatment in neutrophil-depleted mice.
• Fig. S8. Flow cytometry plots from skin samples.
• Fig. S9. Flow cytometry plots from lymph node samples.

Download PDF